INSIGHT-Pharma asks the money question earlier for new drugs

Nils Behnke, Bain & Company Healthcare Partner, is quoted in a Reuters article on the reasons pharmaceutical drug development is slowing. Former Pfizer research chief, John LaMattina comments, "When you're doing market research, people are basing their responses and judgments on what's known and not necessarily looking out of the box." Behnke also adds, "you find other uses, you find combinations, you find other indications -- so many things can happen."